US › Healthcare

MeiraGTx Holdings PLC (MGTX)

US · Healthcare · Biotechnology

$12.29+3.45%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$293,000
Revenue YoY
-84.8%
Net profit
$-46.3M
Profit YoY
-15.8%
EPS
$-0.57
EPS estimate
$-0.45
Net margin
-15,806.5%

EPS came in at -0.57 against a street estimate of -0.45 — a miss of 26.7%.

Key statistics

Market cap
$1.10B
Forward P/E
1.6
P/B
228.30
Book value
$-0.71
EPS (TTM)
$-1.48
52-week high
$15.35
52-week low
$6.62
50-day MA
$11.34
200-day MA
$9.08
Beta
1.25

Analyst view

Analysts rate MeiraGTx Holdings PLC a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $30.00.

Shareholding

Insiders
17.06%
Institutions
61.61%

Largest institutional holders

FundStake
Sanofi13.17%
Perceptive Advisors LLC11.15%
Rubric Capital Management LP7.56%
Johnson & Johnson7.17%
Adage Capital Partners Gp LLC4.32%
Millennium Management LLC3.74%
BlackRock Inc3.42%
Prosight Management, LP2.84%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MeiraGTx Holdings PLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.